Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

U Sahin

Showing results (61-70 of 66) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 66 results.
Cancer Research|September 2, 2000
Naturally occurring human lymphocyte antigen-A2 restricted CD8+ T-cell response to the cancer testis antigen NY-ESO-1 in melanoma patientsD Valmori, V Dutoit, D Liénard, et al.
Biomaterials|December 4, 2018
Investigation of charge ratio variation in mRNA - DEAE-dextran polyplex delivery systemsC Siewert, H Haas, T Nawroth, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 21, 2021
FAST: a randomised phase II study of zolbetuximab (IMAB362) plus EOX versus EOX alone for first-line treatment of advanced CLDN18.2-positive gastric and gastro-oesophageal adenocarcinomaU Sahin, Ö Türeci, G Manikhas, et al.
The European Respiratory Journal|January 9, 2009
Prevalence and Risk Factors of Allergies in Turkey (PARFAIT): results of a multicentre cross-sectional study in adultsE Kurt, S Metintas, I Basyigit, et al.
Nature|February 18, 2026
Individualized mRNA vaccines evoke durable T cell immunity in adjuvant TNBCU Sahin, M Schmidt, E Derhovanessian, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 27, 2019
A multicentre, phase IIa study of zolbetuximab as a single agent in patients with recurrent or refractory advanced adenocarcinoma of the stomach or lower oesophagus: the MONO studyO Türeci, U Sahin, H Schulze-Bergkamen, et al.
Pageof 7

Showing results (61-70 of 66) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 66 results.
Cancer Research|September 2, 2000
Naturally occurring human lymphocyte antigen-A2 restricted CD8+ T-cell response to the cancer testis antigen NY-ESO-1 in melanoma patientsD Valmori, V Dutoit, D Liénard, et al.
Biomaterials|December 4, 2018
Investigation of charge ratio variation in mRNA - DEAE-dextran polyplex delivery systemsC Siewert, H Haas, T Nawroth, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 21, 2021
FAST: a randomised phase II study of zolbetuximab (IMAB362) plus EOX versus EOX alone for first-line treatment of advanced CLDN18.2-positive gastric and gastro-oesophageal adenocarcinomaU Sahin, Ö Türeci, G Manikhas, et al.
The European Respiratory Journal|January 9, 2009
Prevalence and Risk Factors of Allergies in Turkey (PARFAIT): results of a multicentre cross-sectional study in adultsE Kurt, S Metintas, I Basyigit, et al.
Nature|February 18, 2026
Individualized mRNA vaccines evoke durable T cell immunity in adjuvant TNBCU Sahin, M Schmidt, E Derhovanessian, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 27, 2019
A multicentre, phase IIa study of zolbetuximab as a single agent in patients with recurrent or refractory advanced adenocarcinoma of the stomach or lower oesophagus: the MONO studyO Türeci, U Sahin, H Schulze-Bergkamen, et al.
Pageof 7